ALK changes approach to US market entry: "We want to see some results before we make more investments"
The US is a very important market for ALK, and one that ALK very much wants to be successful in. But based on past experiences, ALK will invest differently on the other side of the Atlantic in the future, ALK CEO Peter Halling and ALK CFO Claus Sølje say in an interview with MedWatch at ALK’s Capital Markets Day.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.